Prevalence, Clinical Features, Treatment, and Outcomes in Patients With Myocardial Infarction With Non-Obstructive
T H Hoang1, V V Maiskov2, I A Merai2
1Pham Ngoc Thach University of Medicine; Tam Duc Cardiology Hospital.
Kardiologiia
|August 5, 2024
Summary
Myocardial infarction with non-obstructive coronary arteries (MINOCA) affects 10.3% of acute myocardial infarction patients. MINOCA patients face similar mortality risks but higher rehospitalization rates compared to those with obstructive coronary arteries.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Myocardial infarction with non-obstructive coronary arteries (MINOCA) is increasingly recognized.
- Understanding MINOCA's characteristics and outcomes is crucial for patient management.
Purpose of the Study:
- To compare clinical and demographic profiles of MINOCA patients versus those with myocardial infarction with obstructive coronary arteries (MIOCA).
- To evaluate treatment patterns and clinical outcomes, including mortality and rehospitalization, in MINOCA versus MIOCA patients.
Main Methods:
- A single-center prospective observational study of 712 acute myocardial infarction patients undergoing coronary angiography.
- Patients were categorized into MINOCA (coronary stenosis <50%) and MIOCA (coronary stenosis ≥50%).
- Clinical outcomes assessed included in-hospital and long-term mortality and cardiovascular rehospitalization over a median 1.5-year follow-up.
Main Results:
- MINOCA was diagnosed in 10.3% of patients, with 50% being women.
- No significant differences in cardiovascular risk factors were observed between MINOCA and MIOCA groups.
- MINOCA patients were less likely to receive standard cardiovascular medications and had higher rates of cardiovascular rehospitalization (33.3% vs. 21.5%).
- In-hospital and long-term mortality were comparable between MINOCA and MIOCA groups.
Conclusions:
- MINOCA represents a significant proportion of acute myocardial infarction cases.
- MINOCA patients share similar risk factors with MIOCA patients but exhibit distinct treatment patterns.
- MINOCA is associated with a comparable mortality risk but a higher risk of cardiovascular rehospitalization compared to MIOCA.
Related Concept Videos
Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
474
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
474
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Antianginal Drugs: Nitrates and β-Blockers
557
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
557
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Pathophysiology of Cardiac Performance
623
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
623


